Clinical Trials on Infection, Coronavirus in Poland

Total 2845 results

Restorbio Inc.

Terminated

Phase 2 Study to Determine if RTB101 Reduces the Severity of COVID-19 in Older Adults Residing in Nursing Homes

COVID19

United States
Oregon Health and Science University
OHSU Knight Cancer Institute

Withdrawn

Assessing Hydroxychloroquine in Patients With SARS-CoV-2 (COVID-19)

COVID-19 | SARS-CoV-2

United States
Oystershell NV

Completed

Clinical Trial to Evaluate Efficacy and Safety of a Cryogenic Medical Device for Treatment of Common and Plantar Warts

Warts

Poland
UMC Utrecht
Radboud University Medical Center

Completed

Reducing Health Care Workers Absenteeism in Covid-19 Pandemic Through BCG Vaccine (BCG-CORONA)

COVID-19

Netherlands
BioNTech SE
Pfizer

Completed

Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals

COVID-19 | SARS-CoV-2 Infection

United States, Germany, Turkey, South Africa, Argentina, Brazil
Merck Sharp & Dohme LLC

Completed

Safety and Immunogenicity of 9-valent Human Papillomavirus (9vHPV) Vaccine Coadministered With Messenger Ribonucleic Acid (mRNA)-1273 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (COVID-19) Vaccine (V503-076)

Papillomavirus Infections | Coronavirus Disease (COVID-19)

United States
First Wave BioPharma, Inc.

Active, not recruiting

Safety and Efficacy of Niclosamide in Patients With COVID-19 With Gastrointestinal Infection (RESERVOIR)

Covid19

United States, Ukraine, India
Erasmus Medical Center

Suspended

COVID-19 Resuscitation Plans and Decisions on Escalation and Limitation of Treatment (CORDEAL)

Covid19 | Cardiac Arrest

Netherlands
Karo Pharma AB

Completed

Safety & Effectiveness of Wortie Freeze Plus in Common and Plantar Warts

Plantar Wart | Common Wart

Poland
Leiden University Medical Center

Completed

Unfractionated Heparin in COVID-19 and Non-COVID-19 Patients

COVID-19 | Heparin Overdose of Undetermined Intent

Netherlands
Johns Hopkins University

Completed

Convalescent Plasma to Stem Coronavirus (CSSC-001) (CSSC-001)

Coronavirus | Convalescence

United States
Gilead Sciences

Approved for marketing

Expanded Access Treatment Protocol: Remdesivir (RDV; GS-5734) for the Treatment of SARS-CoV2 (CoV) Infection (COVID-19)

SARS-CoV2 Infection

United States, Israel, Belgium, Spain, Australia, Denmark, Italy, Germany, France, Portugal, United Kingdom, Poland, Switzerland, Canada, Austria, Cyprus, Czechia, Estonia, Greece, Hungary, Iceland, Ireland, Lithuania, Netherlands, Romania and more
Novartis Vaccines
GlaxoSmithKline

Completed

Persistence of Antibody Response to N. Meningitidis Group C in Children

Prevention of Meningococcal Infection

Spain, Poland
Medicago

Active, not recruiting

Study of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine in Adults

SARS-CoV-2 Infection

United States, Canada, United Kingdom, Argentina, Brazil, Mexico
Ansun Biopharma, Inc.

Recruiting

Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study

COVID-19 | Lower Respiratory Tract Infection | Immunocompromised | Parainfluenza

United States, Australia, China, Denmark, France, Hong Kong, Korea, Republic of, Taiwan
The Miriam Hospital

Unknown

Gut Microbiota Changes After Fecal Microbiota Transplantation

Clostridium Difficile Infection

United States
Montefiore Medical Center
University of Bristol; The Fortune Society

Recruiting

Leveraging CHWs to Improve COVID-19 Testing and Mitigation Among CJIs Accessing a Corrections-focused CBO

Covid19

United States
RedHill Biopharma Limited

Completed

Opaganib, a Sphingosine Kinase-2 (SK2) Inhibitor in COVID-19 Pneumonia

COVID-19 | Lung Infection

United States, Brazil, Colombia, Israel, Italy, Mexico, Peru, Poland, Russian Federation, United Kingdom
Medical University of Warsaw

Unknown

LGG for Prevention of Infectious Complications During PPI Treatment in Children

Respiratory Tract Infections | Gastroesophageal Reflux Disease | Gastrointestinal Infections

Poland
Rhode Island Hospital

Terminated

Thymalfasin (Thymosin Alpha 1) to Treat COVID-19 Infection (Ta1)

Covid19

United States
The Miriam Hospital

Completed

Short Term Corticosteroids in SARS-CoV2 Patients

SARS-CoV 2 | Covid19 | Dexamethasone | Steroids | Corticosteroids

United States
Enzychem Lifesciences Corporation

Recruiting

Prevention of COVID-19 Infection to Severe Pneumonia or ARDS

Covid19 Pneumonia

United States
Pfizer
CVS Caremark

Recruiting

Patient Reported Health-Related Quality of Life Associated With COVID-19

COVID-19

United States
Hospital Provincial de Castellon

Recruiting

Low Dose Pulmonary Irradiation in Patients With COVID-19 Infection of Bad Prognosis (COVRTE-19)

Pneumonia, Viral | COVID

Spain
NYU Langone Health
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Understanding the Long-term Impact of COVID on Children and Families

SARS-CoV-2 Infection

United States
BioNTech SE
Pfizer

Completed

A Phase 1/2/3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of an RNA Vaccine Candidate Against COVID-19 in Healthy Children

SARS-CoV-2 Infection, COVID-19

United States, Spain, Finland, Poland, Mexico, Brazil
SerenaGroup, Inc.
SerenaGroup Research Foundation

Unknown

Compassionate Use of Hyperbaric Oxygen Therapy

COVID-19

United States, Poland
Public Health Service of Amsterdam
ZonMw: The Netherlands Organisation for Health Research and Development; Amsterdam... and other collaborators

Recruiting

Interventions to Curb Hepatitis C Reinfections Among Men Who Have Sex With Men (ICECREAM)

Hepatitis C Virus Infection

Netherlands, France
Pfizer

Completed

TBE Antibody Persistence and Booster Vaccination Study in Adults (Follow-up to Study 223)

Encephalitis, Tick-Borne

Poland
Pfizer

Completed

Immunogenicity and Safety Study of FSME-IMMUN 0.5 mL in Adult Subjects Previously Vaccinated According to a Rapid Immunization Schedule

Encephalitis, Tick-Borne

Poland
Jagiellonian University

Completed

The Impact of the Type and Route of Nutritional Support on Infectious Complications After Upper Gastrointestinal Surgery

Gastrointestinal Surgery

Poland
Novavax

Active, not recruiting

Phase 2/3 Heterologous Boosting Study With Different Dose Levels of Monovalent SARS-CoV-2 rS Vaccines (COVID-19)

COVID-19

United States
National Institute of Allergy and Infectious Diseases...

Completed

The Effect of Acyclovir Treatment of the Herpes Simplex Virus (HSV) Infection on HIV Levels in the Blood

HIV Infections | Herpes Simplex

United States
Marcin Straburzynski

Completed

Phenotype of Headache and Facial Pain in Upper Respiratory Tract Infections

Upper Respiratory Tract Infections

Poland
Rhode Island Hospital
Blackstone Valley Community Health Care

Unknown

Improving Cancer Screening and Prevention During the COVID-19 Pandemic in Underserved Populations of Rhode Island

Breast Cancer | Covid19 | Colorectal Cancer

United States
BioNTech SE
Pfizer

Completed

A Study to Learn About New COVID-19 RNA Vaccine Candidates in COVID-19 Vaccine-Experienced Healthy Individuals

COVID-19 | SARS-CoV-2 Infection

United States
Novartis Vaccines

Completed

Immunogenicity, Safety, Tolerability and Ability to Prime for Memory of Meningococcal C Conjugate Vaccine in Healthy Children

Prevention of Meningococcal Infection

Germany, Poland
Pfizer

Completed

Investigation of the Seropersistence of TBE Antibodies and the Booster Response to FSME-IMMUN 0.5 ml in Adults Aged 18 - 67 Years

Tick-borne Encephalitis

Poland
PTC Therapeutics

Terminated

A Study to Evaluate Efficacy and Safety of PTC299 (Emvododstat) in Hospitalized Participants With Coronavirus (COVID-19) (FITE19)

COVID-19 | Pneumonia | Coronavirus

Spain, United States, Australia, France, Brazil, Mexico, South Africa, Belgium, Colombia, Poland, Portugal
Astellas Pharma Europe Ltd.
Cubist Pharmaceuticals LLC

Terminated

A Post-marketing, Blinded Study to Investigate How Effective Fidaxomicin is Compared to Vancomycin in the Sustained Cure of Clostridium Difficile Infection in Adults That Are Receiving Therapy to Suppress the Immune System (FREEDOM)

Clostridium Difficile

Spain, France, Germany, Greece, Denmark, Austria, Poland
National Institute of Allergy and Infectious Diseases...

Completed

A Study of SARS CoV-2 Infection and Potential Transmission in Individuals Immunized With Moderna COVID-19 Vaccine (CoVPN 3006)

SARS-CoV-2 Infection

United States
Novavax

Completed

Phase 3 Study of Novavax Vaccine(s) as Booster Dose After mRNA Vaccines

COVID-19

United States
Pfizer

Completed

TBE Seropersistence up to 10 Years After First Booster in Adults

Tick-borne Encephalitis (TBE)

Poland
Merck Sharp & Dohme LLC

Completed

Study of MK-4482 for Prevention of Coronavirus Disease 2019 (COVID-19) in Adults (MK-4482-013) (MOVe-AHEAD)

Coronavirus Disease (COVID-19)

United States, Argentina, Brazil, Bulgaria, Colombia, Dominican Republic, Egypt, France, Guatemala, Hungary, Japan, Kenya, Malaysia, Mexico, Peru, Philippines, Romania, Russian Federation, South Africa, Spain, Thailand, Turkey, Ukraine
National Institute of Allergy and Infectious Diseases...
Boston Children's Hospital; Benaroya Research Institute

Completed

Immunophenotyping Assessment in a COVID-19 Cohort (IMPACC)

SARS-CoV-2 | Coronavirus Disease 2019 (COVID-19)

United States
Jagiellonian University

Completed

Assesment of the Endotracheal Tube Cuff Pressure Values in ICU Pateints Before and After Training Seminar

Respiratory Tract Infections | Respiratory Tract Diseases | Ventilator-Induced Lung Injury | Pneumonia, Ventilator-Associated

Poland
Katarina Hedin
National University of Ireland, Galway, Ireland; Utrecht University; Research...

Recruiting

COVID-19 And Lingering Symptoms In Primary Care Patients (CALIP)

Covid19 | Symptoms and Signs

Belgium, Denmark, France, Georgia, Germany, Ireland, Italy, Netherlands, Poland, Romania, Sweden
Jagiellonian University

Completed

TREM-1 - a New Marker of Serious Infectious Complications in Colorectal Surgery?

Colorectal (Colon or Rectal) Cancer

Poland
Hope Biosciences Stem Cell Research Foundation
Hope Biosciences

Completed

A Clinical Trial to Determine the Safety and Efficacy of HB-adMSCs to Provide Protection Against COVID-19

COVID-19

United States
Hope Biosciences Stem Cell Research Foundation
Hope Biosciences

Completed

A Randomized, Double-Blind, Single Center, Efficacy and Safety Study of Allogeneic HB-adMSCs Against COVID-19.

COVID-19

United States

Clinical Trials on Infection, Coronavirus in Poland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Moldova

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations